Skip to main content

Gemma Español Martín

Institutions of which they are part

Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital
Doctor
Psychiatry
Children's Hospital and Woman's Hospital

Gemma Español Martín

Institutions of which they are part

Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital
Doctor
Psychiatry
Children's Hospital and Woman's Hospital

Projects

Más allá del riesgo genético para el TDAH: contribución genética a la resiliencia en una muestra clínica

IP: Marta Ribases Haro
Collaborators: Montserrat Corrales De la Cruz, Judit Cabana Dominguez, Laura Gisbert Gustemps, Gemma Español Martín, Vanesa Richarte Fernández, Christian Fadeuilhe Grau
Funding agency: Instituto de Salud Carlos III
Funding: 131250
Reference: PI23/00404
Duration: 01/01/2024 - 31/12/2026

ESTUDIO DE SEGUIMIENTO DEL TRASTORNO LIMITE DE PERSONALIDAD: REEVALUACION CLINICA Y DE NEUROIMAGEN A LOS 6 AÑOS DEL DIAGNÓSTICO EN LA ADOLESCENCIA

IP: Marc Ferrer Vinardell
Collaborators: Natalia Calvo Piñero, Gemma Nieva Rifa, Gemma Español Martín, Alexandre Rue Jimenez, Mar Baz Montero, Gara Arteaga Henriquez
Funding agency: Instituto de Salud Carlos III
Funding: 62920
Reference: PI22/01131
Duration: 01/01/2023 - 31/12/2025

Impact of Neurodevelopmental Disorders on School Performance: genes and environment (INSchool)

IP: Marta Ribases Haro
Collaborators: Gemma Español Martín, Judit Cabana Dominguez, José Antonio Ramos Quiroga, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Silvia Alemany Sierra, Natalia Llonga Tejedor, Maria Soler Artigas
Funding agency: Fundació La Marató de TV3
Funding: 199187.5
Reference: 202228-30-31
Duration: 20/04/2023 - 19/04/2026

Trastorno por déficit de Atención con Hiperactividad, Puntuación de Riesgo Poligénico para alteraciones neurocognitivas, trastornos del aprendizaje y bajo rendimiento escolar

IP: Miquel Casas Brugué
Collaborators: Gemma Español Martín
Funding agency: Instituto de Salud Carlos III
Funding: 219615
Reference: PI16/01505
Duration: 01/01/2017 - 30/09/2020

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Anna Sanjuan Viaplana

Anna Sanjuan Viaplana

Medium Grade Technician
Statistics and Bioinformatics Unit (UEB)
Preclinical Core Facilities
External Strategy Directorate
Read more
Garcia Blanco, Alejandra

Garcia Blanco, Alejandra

Research technician
Neurodegenerative Diseases
Read more
Joan Compte Barrón

Joan Compte Barrón

Predoctoral researcher
Neurodegenerative Diseases
Read more
Piqué Ponti, Julia

Piqué Ponti, Julia

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.